Search Share Prices

GSK Shares - How much should a ‘blockbuster’ drug earn now?

Examples in recent years include Lipitor, a treatment for high cholesterol made by US giant Pfizer Inc (NYSE:PFE), and Advair, an inhaler made by GlaxoSmithKline PLC (LON:GSK). However, three and a ...

Read More »

Premarket London: NMC to Launch Independent Audit Review

Mackenzie will receive around 7% less in stock under the company's long-term incentive program as a result. GlaxoSmithKline (LON:GSK) confirmed that the U.S. Food and Drug Administration had refused ...

Read More »

GlaxoSmithKline (LON:GSK) Hits New 52-Week High on Analyst Upgrade

GlaxoSmithKline plc (LON:GSK)’s stock price reached a new 52-week high on Wednesday after Jefferies Financial Group raised their price target on the stock from GBX 1,850 to GBX 2,000. Jefferies ...

Read More »

GlaxoSmithKline (LON:GSK) Given a GBX 1,700 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. set a GBX 1,700 ($22.36) price target on GlaxoSmithKline (LON:GSK) in a report released on Tuesday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock. A ...

Read More »

Global Chronic Kidney Disease Drugs Market Expected to Grow at a CAGR of 4.5% by 2027

Hoffmann-La Roche (swx:ROG), GlaxoSmithKline plc. (lon:GSK), FibroGen, Inc. FGEN, +0.55%, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd. (tlv:TEVA), AbbVie Inc. ABBV, -1.24% and ...

Read More »

Related Share Prices